Arcellx Inc (NASDAQ: ACLX) on Monday, soared 6.50% from the previous trading day, before settling in for the closing price of $69.56. Within the past 52 weeks, ACLX’s price has moved between $47.86 and $94.07.
Annual sales at Healthcare sector company slipped by -31.14% over the past five years. The company achieved an average annual earnings per share of -106.16%. With a float of $43.24 million, this company’s outstanding shares have now reached $57.78 million.
Arcellx Inc (ACLX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Arcellx Inc is 25.22%, while institutional ownership is 92.01%. The most recent insider transaction that took place on Nov 17 ’25, was worth 30,600. In this transaction CHIEF MEDICAL OFFICER of this company sold 340 shares at a rate of $90.00, taking the stock ownership to the 284 shares. Before that another transaction happened on Oct 15 ’25, when Company’s CHIEF FINANCIAL OFFICER sold 5,364 for $91.04, making the entire transaction worth $488,315. This insider now owns 8,466 shares in total.
Arcellx Inc (ACLX) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.87 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.47) by -0.4. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -106.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.18% during the next five years compared to -31.14% drop over the previous five years of trading.
Arcellx Inc (NASDAQ: ACLX) Trading Performance Indicators
Arcellx Inc (ACLX) is currently performing well based on its current performance indicators. A quick ratio of 3.99 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 119.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.92, a number that is poised to hit -1.06 in the next quarter and is forecasted to reach -3.06 in one year’s time.
Technical Analysis of Arcellx Inc (ACLX)
Arcellx Inc (NASDAQ: ACLX) saw its 5-day average volume 1.98 million, a positive change from its year-to-date volume of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 27.09%.
During the past 100 days, Arcellx Inc’s (ACLX) raw stochastic average was set at 28.79%, which indicates a significant decrease from 30.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 5.70 in the past 14 days, which was higher than the 3.61 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $83.91, while its 200-day Moving Average is $71.39. Nevertheless, the first resistance level for the watch stands at $79.32 in the near term. At $84.57, the stock is likely to face the second major resistance level. The third major resistance level sits at $89.38. If the price goes on to break the first support level at $69.26, it is likely to go to the next support level at $64.45. Assuming the price breaks the second support level, the third support level stands at $59.20.
Arcellx Inc (NASDAQ: ACLX) Key Stats
Market capitalization of the company is 4.28 billion based on 57,823K outstanding shares. Right now, sales total 107,940 K and income totals -107,350 K. The company made 4,950 K in profit during its latest quarter, and -55,780 K in sales during its previous quarter.
